Sherry Rais

Sherry Rais, CEO/Co-Founder of Enthea, discusses offering psychedelic therapy through employer health plans, personal anecdotes on running and cultural influences, advocating for mental health equity, expanding access to psychedelic therapy services, implementing ketamine-assisted therapy for employers, and the global deployment of psychedelic medicines.

Sherry Rais, CEO of Enthea, discusses providing psychedelic-assisted therapy as a workplace benefit, global disparities in research, historical perspectives on psychedelics, various access models, and Enthea's expansion into psilocybin therapy.

Sherry Rais, CEO of Anthea, discusses pioneering accessible psychedelic-assisted therapies, starting with ketamine treatment. They explore the transformative potential of these therapies, challenges in integrating psychedelic therapy into insurance policies, and the benefits of offering ketamine therapy as an employee benefit. The podcast also addresses stigma associated with psychedelic therapy, underutilization of mental health benefits post-COVID, and the importance of personalized treatments for better mental health outcomes.